Figure. Screening, Enrollment, Randomization, and Follow-Up of Participants in the WINGS Trial.

^aNeurodevelopment assessments done for a subsample of children born between November 1, 2018, and February 25, 2020, as the secondary outcome of the previously published WINGS trial.¹¹ All families were approached consecutively for assessment soon after their child attained 24 months of age, until the required sample size was achieved. There were no refusals; however, some children (and their families) had moved out of the study area at the time of their scheduled assessment (referred to as “not available”).

^bTwo twins.

^cTwo twins.

^dThree twins.

^eTwo twins.